Failure to report protocol violations in clinical trials: A threat to internal validity?

Trials

Volumn 12, Issue , 2011, Pages

  Sweetman, Elizabeth A ^a   Doig, Gordon S ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

Clinical trials; Errors of conduct; Methodology; Methods; Protocol deviations; Protocol violations; Randomised; Randomized; Reporting artifact

Indexed keywords

ARTICLE; ARTIFACT; CLINICAL TRIAL (TOPIC); INTERNAL VALIDITY; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; PARTICIPANT OBSERVATION; PATIENT COMPLIANCE; RANDOMIZATION; CLINICAL PROTOCOL; HUMAN; REPRODUCIBILITY; STANDARD;

CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 80053344855     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-214     Document Type: Article

References (25)

1. DiFrancesco R, Rosenkranz SL, Craft J, Morse GD. Tutorial reduces protocol deviations in multicenter ACTG trials with pharmacology endpoints. HIV Clinical Trials 2006, 7:203-209. 10.1310/hct0704-203, 17065032.
2. Macias WL, Vallet B, Bernard GR, Vincent JL, Laterre PF, Nelson DR, Derchak A, Dhainaut JF. Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsis. Crit Care Med 2004, 32:2385-2391. 10.1097/01.CCM.0000147440.71142.AC, 15599140.
3. Pocock SJ. Protocol Deviations. Clinical Trials: A Practical Approach 1983, 176-186. New York: John Wiley & Sons, Pocock SJ.
4. Sprung CL, Finch RG, Thijs LG, Glauser MP. International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med 1996, 24:1441-1447. 10.1097/00003246-199609000-00003, 8797613.
5. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773.
6. Simpson F, Sweetman EA, Doig GS. A systematic review of techniques and interventions for improving adherence to inclusion and exclusion criteria during enrolment into randomised controlled trials. Trials 2010, 11:11-17. 10.1186/1745-6215-11-11, 2832639, 20137079.
7. Doig GS, Simpson F, Sweetman EA. Use of a formal study run-in phase to reduce recruitment errors in a multicentre randomised controlled trial: is quality better than quantity?[Abstract]. Asia Pacific Critical Care Congress - Sydney, Congress Guide: 30 October - 2nd November 2008 2008, 79-80. Sydney.
8. Haynes RB, McKibbon KA, Wilczynski NL, Walter SD, Werre SR. Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey. BMJ 2005, 330:1179-1185. 10.1136/bmj.38446.498542.8F, 558012, 15894554.
9. Higgins JPT, Green S. Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, 8.1-8.17. The Cochrane Collaboration, Higgins JPT, Altman DJ, Sterne J., http://www.cochrane-handbook.org
10. Wolf GT, Makuch RW. Editorial: a classification system for protocol deviations in clinical trials. Cancer Clin Trials 1980, 3:101-103.
11. Schulz KF, Altman DG, Moher D, . the CONSORT Group CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epid 2010, 63:834-840. the CONSORT Group.
12. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Alman DG. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010, 63:e1-37. 10.1016/j.jclinepi.2010.03.004, 20346624.
13. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002, 325:652-654. 10.1136/bmj.325.7365.652, 1124168, 12242181.
14. Lachin JL. Statistical considerations in the intent-to-treat principle. Control Clin Trials 2000, 21:526. 10.1016/S0197-2456(00)00092-1, 11018568.
15. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003, 34:2847-2850. 10.1161/01.STR.0000101752.23813.C3, 14605319.
16. Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002, 359:781-785. 10.1016/S0140-6736(02)07882-0, 11888606.
17. Pablos-Mendez A, Barr RG, Shea S. Run-in periods in randomized trials: implications for the application of results in clinical practice. JAMA 1998, 279:222-225. 10.1001/jama.279.3.222, 9438743.
18. Meinert CL. Organization of multicenter clinical trials. Control Clin Trials 1981, 1:305-312. 10.1016/0197-2456(81)90033-7, 7261620.
19. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 2006, 185:263-267.
20. Doig GS, Simpson F, Delaney A. A review of the true methodological quality of nutritional support trials conducted in the critically ill: time for improvement. Anesth Analg 2005, 100:527-533. 10.1213/01.ANE.0000141676.12552.D0, 15673887.
21. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999, 319:670-674. 28218, 10480822.
22. Wood AM, White IR, Thompson SG. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials 2004, 1:368-376. 10.1191/1740774504cn032oa, 16279275.
23. Hewitt C, Hahn S, Torgerson DJ, Watson J, Bland JM. Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals. BMJ 2005, 330:1057-1058. 10.1136/bmj.38413.576713.AE, 557225, 15760970.
24. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 2002, 21:2917-2930. 10.1002/sim.1296, 12325108.
25. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005, 365:1159-1162. 10.1016/S0140-6736(05)71879-1, 15794971.